▶ 調査レポート

世界の結腸直腸癌治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の結腸直腸癌治療市場規模・現状・予測(2021年-2027年) / Global Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027 / QFJ1-4037資料のイメージです。• レポートコード:QFJ1-4037
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、結腸直腸癌治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(標的療法、免疫療法、化学療法、その他)、用途別市場規模(病院、診療所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・結腸直腸癌治療の市場動向
・企業の競争状況、市場シェア
・結腸直腸癌治療の種類別市場規模と予測2016-2027(標的療法、免疫療法、化学療法、その他)
・結腸直腸癌治療の用途別市場規模と予測2016-2027(病院、診療所)
・結腸直腸癌治療の北米市場規模2016-2027(アメリカ、カナダ)
・結腸直腸癌治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・結腸直腸癌治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・結腸直腸癌治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・結腸直腸癌治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Eli Lilly、Ipsen、Pfizer、Teva、Bristol Myers Squibb、Sanofi、Merck Sharp & Dohme Corp.、Otsuka Pharmaceutical、Bayer、Regeneron、Novartis)
・結論

Colorectal cancer therapeutics market trends, there are a number of factors providing major impetus to the growth of these drugs.

Market Analysis and Insights: Global Colorectal Cancer Treatment Market
The global Colorectal Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Treatment market.

Global Colorectal Cancer Treatment Scope and Market Size
Colorectal Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Therapy
Immunotherapy
Chemotherapy
Others

Segment by Application
Hospitals
Clinics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Ipsen
Pfizer
Teva
Bristol Myers Squibb
Sanofi
Merck Sharp & Dohme Corp.
Otsuka Pharmaceutical
Bayer
Regeneron
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Colorectal Cancer Treatment Market Perspective (2016-2027)
2.2 Colorectal Cancer Treatment Growth Trends by Regions
2.2.1 Colorectal Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Treatment Industry Dynamic
2.3.1 Colorectal Cancer Treatment Market Trends
2.3.2 Colorectal Cancer Treatment Market Drivers
2.3.3 Colorectal Cancer Treatment Market Challenges
2.3.4 Colorectal Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Treatment Players by Revenue
3.1.1 Global Top Colorectal Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Treatment Revenue
3.4 Global Colorectal Cancer Treatment Market Concentration Ratio
3.4.1 Global Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Treatment Revenue in 2020
3.5 Colorectal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Treatment Breakdown Data by Type
4.1 Global Colorectal Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Treatment Breakdown Data by Application
5.1 Global Colorectal Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Colorectal Cancer Treatment Market Size (2016-2027)
6.2 North America Colorectal Cancer Treatment Market Size by Type
6.2.1 North America Colorectal Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Treatment Market Size by Application
6.3.1 North America Colorectal Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Treatment Market Size by Country
6.4.1 North America Colorectal Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Colorectal Cancer Treatment Market Size (2016-2027)
7.2 Europe Colorectal Cancer Treatment Market Size by Type
7.2.1 Europe Colorectal Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Treatment Market Size by Application
7.3.1 Europe Colorectal Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Treatment Market Size by Country
7.4.1 Europe Colorectal Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Colorectal Cancer Treatment Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Treatment Market Size by Type
9.2.1 Latin America Colorectal Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Treatment Market Size by Application
9.3.1 Latin America Colorectal Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Treatment Market Size by Country
9.4.1 Latin America Colorectal Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Colorectal Cancer Treatment Introduction
11.1.4 Eli Lilly Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Ipsen
11.2.1 Ipsen Company Details
11.2.2 Ipsen Business Overview
11.2.3 Ipsen Colorectal Cancer Treatment Introduction
11.2.4 Ipsen Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.2.5 Ipsen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Colorectal Cancer Treatment Introduction
11.3.4 Pfizer Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Colorectal Cancer Treatment Introduction
11.4.4 Teva Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Bristol Myers Squibb
11.5.1 Bristol Myers Squibb Company Details
11.5.2 Bristol Myers Squibb Business Overview
11.5.3 Bristol Myers Squibb Colorectal Cancer Treatment Introduction
11.5.4 Bristol Myers Squibb Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.5.5 Bristol Myers Squibb Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Colorectal Cancer Treatment Introduction
11.6.4 Sanofi Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Merck Sharp & Dohme Corp.
11.7.1 Merck Sharp & Dohme Corp. Company Details
11.7.2 Merck Sharp & Dohme Corp. Business Overview
11.7.3 Merck Sharp & Dohme Corp. Colorectal Cancer Treatment Introduction
11.7.4 Merck Sharp & Dohme Corp. Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.7.5 Merck Sharp & Dohme Corp. Recent Development
11.8 Otsuka Pharmaceutical
11.8.1 Otsuka Pharmaceutical Company Details
11.8.2 Otsuka Pharmaceutical Business Overview
11.8.3 Otsuka Pharmaceutical Colorectal Cancer Treatment Introduction
11.8.4 Otsuka Pharmaceutical Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.8.5 Otsuka Pharmaceutical Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Colorectal Cancer Treatment Introduction
11.9.4 Bayer Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Regeneron
11.10.1 Regeneron Company Details
11.10.2 Regeneron Business Overview
11.10.3 Regeneron Colorectal Cancer Treatment Introduction
11.10.4 Regeneron Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.10.5 Regeneron Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Colorectal Cancer Treatment Introduction
11.11.4 Novartis Revenue in Colorectal Cancer Treatment Business (2016-2021)
11.11.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Colorectal Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Others
Table 6. Global Colorectal Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Colorectal Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Colorectal Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Colorectal Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Colorectal Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Colorectal Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Colorectal Cancer Treatment Market Trends
Table 13. Colorectal Cancer Treatment Market Drivers
Table 14. Colorectal Cancer Treatment Market Challenges
Table 15. Colorectal Cancer Treatment Market Restraints
Table 16. Global Colorectal Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Colorectal Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Colorectal Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colorectal Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Colorectal Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Colorectal Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Colorectal Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Colorectal Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Colorectal Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Colorectal Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Colorectal Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Colorectal Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Colorectal Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Colorectal Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Colorectal Cancer Treatment Product
Table 66. Eli Lilly Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Ipsen Company Details
Table 69. Ipsen Business Overview
Table 70. Ipsen Colorectal Cancer Treatment Product
Table 71. Ipsen Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Ipsen Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Colorectal Cancer Treatment Product
Table 76. Pfizer Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Teva Company Details
Table 79. Teva Business Overview
Table 80. Teva Colorectal Cancer Treatment Product
Table 81. Teva Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. Teva Recent Development
Table 83. Bristol Myers Squibb Company Details
Table 84. Bristol Myers Squibb Business Overview
Table 85. Bristol Myers Squibb Colorectal Cancer Treatment Product
Table 86. Bristol Myers Squibb Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Bristol Myers Squibb Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Colorectal Cancer Treatment Product
Table 91. Sanofi Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Merck Sharp & Dohme Corp. Company Details
Table 94. Merck Sharp & Dohme Corp. Business Overview
Table 95. Merck Sharp & Dohme Corp. Colorectal Cancer Treatment Product
Table 96. Merck Sharp & Dohme Corp. Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Merck Sharp & Dohme Corp. Recent Development
Table 98. Otsuka Pharmaceutical Company Details
Table 99. Otsuka Pharmaceutical Business Overview
Table 100. Otsuka Pharmaceutical Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Otsuka Pharmaceutical Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Colorectal Cancer Treatment Product
Table 105. Bayer Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 106. Bayer Recent Development
Table 107. Regeneron Company Details
Table 108. Regeneron Business Overview
Table 109. Regeneron Colorectal Cancer Treatment Product
Table 110. Regeneron Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 111. Regeneron Recent Development
Table 112. Novartis Company Details
Table 113. Novartis Business Overview
Table 114. Novartis Colorectal Cancer Treatment Product
Table 115. Novartis Revenue in Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 116. Novartis Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Targeted Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Others Features
Figure 6. Global Colorectal Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Colorectal Cancer Treatment Report Years Considered
Figure 10. Global Colorectal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Colorectal Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Colorectal Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Colorectal Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Colorectal Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Treatment Revenue in 2020
Figure 17. Global Colorectal Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Colorectal Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Colorectal Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 59. Ipsen Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 61. Teva Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 62. Bristol Myers Squibb Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 64. Merck Sharp & Dohme Corp. Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 65. Otsuka Pharmaceutical Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 67. Regeneron Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Colorectal Cancer Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed